EXPERIENCE WITH VINCRISTINE IN SOLID TUMORS.
D000970:Antineoplastic Agents; D001943:Breast Neoplasms; D006689:Hodgkin Disease; D006801:Humans; D007275:Injections, Intravenous; D007822:Laryngeal Neoplasms; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D008441:Maxillary Neoplasms; D009303:Nasopharyngeal Neoplasms; D009369:Neoplasms; D010178:Pancoast Syndrome; D012509:Sarcoma; D014116:Toxicology; D001749:Urinary Bladder Neoplasms; D014750:Vincristine
D000970:Antineoplastic Agents; D014750:Vincristine
ANTINEOPLASTIC AGENTS; BLADDER NEOPLASMS; BREAST NEOPLASMS; HODGKIN'S DISEASE; INJECTIONS, INTRAVENOUS; LARYNGEAL NEOPLASMS; LYMPHOSARCOMA; MAXILLARY NEOPLASMS; NASOPHARYNGEAL NEOPLASMS; PANCOAST'S SYNDROME; SARCOMA, RETICULUM CELL; TOXICOLOGIC REPORT; VINCRISTINE